CANbridge Pharmaceuticals to Participate in the Morgan Stanley Virtual China Summit 2022
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc. (HKEX:1228), a China-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, today announced that it will participate in the Morgan Stanley Virtual China Summit 2022 to be held on May 24-26, 2022. About CANbridge Pharmaceuticals Inc. CANbridge Pharmaceuticals … [Read more…]